Brief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
BRIEF-Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA Oct 23 (Reuters) - Phathom Pharmaceuticals, Inc. PHAT.O:
PHATHOM PHARMACEUTICALS INC: BDR PHARMACEUTICALS HAS FILED SUIT AGAINST FDA AND RELATED FEDERAL DEFENDANTS IN UNITED STATES DISTRICT COURT
PHATHOM PHARMACEUTICALS PROVIDES UPDATE ON LITIGATION FILED BY BDR PHARMACEUTICALS AGAINST FDA
PHATHOM PHARMACEUTICALS, INC.: INTENDS TO TAKE APPROPRIATE ACTION TO PROTECT ITS STATUTORY EXCLUSIVITIES.
Further company coverage: PHAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates